AAAAAA
Results:
1-17
|
Results: 17
Authors:
BURNOUF T
GOUBRAN H
RADOSEVICH M
Citation: T. Burnouf et al., APPLICATION OF BIOAFFINITY TECHNOLOGY IN THERAPEUTIC EXTRACORPOREAL PLASMAPHERESIS AND LARGE-SCALE FRACTIONATION OF HUMAN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 715(1), 1998, pp. 65-80
Authors:
VANKEMMEL O
DELATAILLE A
RIGOT JM
BURNOUF T
MAZEMAN E
Citation: O. Vankemmel et al., VASAL REANASTOMOSIS USING FIBRIN GLUE COMBINED WITH SUTURES - WHICH COMBINATION OF SUTURES IN A DELAYED PROTOCOL - EXPERIMENTAL-STUDY IN RATS, European urology, 33(3), 1998, pp. 318-322
Authors:
FLAMENT MP
LETERME P
BURNOUF T
GAYOT AT
Citation: Mp. Flament et al., EVALUATION OF THE EFFECTIVENESS OF DIFFERENT ANTIFOAMS FOR AN ALPHA(1)PI SOLUTION, International journal of pharmaceutics, 156(2), 1997, pp. 211-217
Authors:
FLAMENT MP
LETERME P
BURNOUF T
GAYOT AT
Citation: Mp. Flament et al., JET NEBULIZATION - INFLUENCE OF DYNAMIC CONDITIONS AND NEBULIZER ON NEBULIZATION QUALITY - APPLICATION TO THE ALPHA-1 PROTEASE INHIBITOR, International journal of pharmaceutics, 148(1), 1997, pp. 93-101
Authors:
VANKEMMEL O
RIGOT JM
BURNOUF T
MAZEMAN E
Citation: O. Vankemmel et al., DELAYED VASOVASOSTOMY - EXPERIMENTAL-STUDY USING FIBRIN GLUE, European urology, 31(2), 1997, pp. 182-186
Authors:
RADOSEVICH M
GOUBRAN HA
BURNOUF T
Citation: M. Radosevich et al., FIBRIN SEALANT - SCIENTIFIC RATIONALE, PRODUCTION METHODS, PROPERTIES, AND CURRENT CLINICAL USE, Vox sanguinis, 72(3), 1997, pp. 133-143
Authors:
BURNOUF T
Citation: T. Burnouf, VALUE OF VIRUS FILTRATION AS A METHOD FOR IMPROVING THE SAFETY OF PLASMA PRODUCTS, Vox sanguinis, 70(4), 1996, pp. 235-236
Authors:
MIZON C
BALDUYCK M
ALBANI D
MICHALSKI C
BURNOUF T
MIZON J
Citation: C. Mizon et al., DEVELOPMENT OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HUMAN PLASMA INTER-ALPHA-TRYPSIN INHIBITOR (ITI) USING SPECIFIC ANTIBODIES AGAINST EACH OF THE H-1 AND H-2 HEAVY-CHAINS, Journal of immunological methods, 190(1), 1996, pp. 61-70
Authors:
VANKEMMEL O
RIGOT JM
BURNOUF T
MAZEMAN E
Citation: O. Vankemmel et al., DELAYED VASAL REANASTOMOSIS IN RATS - COMPARISON OF A MICROSURGICAL TECHNIQUE AND A FIBRIN-GLUED PROCEDURE, British Journal of Urology, 78(2), 1996, pp. 271-274
Authors:
BURNOUF T
Citation: T. Burnouf, CHROMATOGRAPHY IN PLASMA FRACTIONATION - BENEFITS AND FUTURE-TRENDS, Journal of chromatography B. Biomedical applications, 664(1), 1995, pp. 3-15
Authors:
LEFRERE JJ
MARIOTTI M
DELACROIX I
LERABLE J
THAUVIN M
BURNOUF T
FOLLEA G
Citation: Jj. Lefrere et al., ALBUMIN BATCHES AND B19 PARVOVIRUS DNA, Transfusion, 35(5), 1995, pp. 389-391
Authors:
ZHOU FL
BURNOUFRADOSEVICH M
BURNOUF T
Citation: Fl. Zhou et al., PURIFICATION OF FACTOR-VIII VON-WILLEBRAND-FACTOR FROM HUMAN PLASMA ON IMMOBILIZED LENTIL LECTIN, Protein expression and purification, 5(2), 1994, pp. 138-143
Authors:
POULLE M
BURNOUFRADOSEVICH M
BURNOUF T
Citation: M. Poulle et al., LARGE-SCALE PREPARATION OF HIGHLY PURIFIED HUMAN C1-INHIBITOR FOR THERAPEUTIC USE, Blood coagulation & fibrinolysis, 5(4), 1994, pp. 543-549
Authors:
BURNOUF T
Citation: T. Burnouf, CURRENT STRATEGIES AIMED AT PREVENTION OF VIRAL CONTAMINATION OF COAGULATION-FACTOR CONCENTRATES, Clinical and laboratory haematology, 16(4), 1994, pp. 398-399
Authors:
MICHALSKI C
PIVA F
BALDUYCK M
MIZON C
BURNOUF T
HUART JJ
MIZON J
Citation: C. Michalski et al., PREPARATION AND PROPERTIES OF A THERAPEUTIC INTER-ALPHA-TRYPSIN INHIBITOR CONCENTRATE FROM HUMAN PLASMA, Vox sanguinis, 67(4), 1994, pp. 329-336
Authors:
BURNOUF T
Citation: T. Burnouf, NEW TRENDS IN PLASMA FRACTIONATION AND PLASMA PRODUCTS TRENDS IN PLASMA FRACTIONATION, Vox sanguinis, 67, 1994, pp. 251-253
Authors:
BURNOUFRADOSEVICH M
APPOURCHAUX P
HUART JJ
BURNOUF T
Citation: M. Burnoufradosevich et al., NANOFILTRATION, A NEW SPECIFIC VIRUS ELIMINATION METHOD APPLIED TO HIGH-PURITY FACTOR-IX AND FACTOR-XI CONCENTRATES, Vox sanguinis, 67(2), 1994, pp. 132-138
Risultati:
1-17
|